Diabetes News

FacebookTwitterEmail
 

Colorado Becomes First State to Pass Bill Capping Insulin Costs


On Wednesday, May 22, Colorado became the first state in the U.S. to put a price cap on insulin.READ MORE

FDA Approves New Treatment for Diabetic Retinopathy


Regeneron Pharmaceuticals announced that the FDA has approved EYLEA (aflibercept) to treat all stages of diabetic retinopathy.READ MORE

Express Scripts Won’t Cover Lilly’s Generic Insulin


The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication. READ MORE

Omnipod DASH System Now Available in the U.S.


The Omnipod DASH™ Insulin Management System is now officially available in the United States following a limited marketing release.READ MORE

European Commission Approves Zynquista, First Dual SGLT Inhibitor for T1D


Zynquista is the first dual SGLT1 and SGLT2 inhibitor approved for use in Type 1 diabetes, and the second oral medication approved for use in Type 1 diabetes. READ MORE

Woman’s Insulin Confiscated By Airport Security


A woman boarding a flight in the UK had her insulin taken from her by airport security and subsequently boarded her flight without it.READ MORE

DIY Loop Now Compatible with Omnipod


Loop announced that a testing branch of their DIY Loop is now compatible with the current 'Eros' generation of Omnipod, and available to the public.READ MORE

Previously Healthy from Beyond Type 1 Named Webby People’s Voice Award Winner


Hailed as the “Internet’s highest honor” and “the Oscars of the Internet” The Webby Awards are presented by the International Academy of Digital Arts and Sciences (IADAS) honoring excellence on the Internet.READ MORE

Insulin Manufacturers and PBMs Testify Before Congress


The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.READ MORE

JDRF’s New CEO Aaron Kowalski Talks to Beyond Type 1


Beyond Type 1 spoke with newly-appointed JDRF CEO Aaron Kowalski about his priorities, the future of T1D research and treatment options, and how his diabetes has informed his work. READ MORE

Cigna Plan Could Cap Insulin Costs at $25 a Month


Cigna and Express Scripts announced on Wednesday that they would be lowering the out-of-pocket cost of insulin for some patients with diabetes.READ MORE

‘Previously Healthy’ Nominated for Best Writing (Editorial) in the 23rd Annual Webby Awards


Type 1 diabetes story nominated for a Webby alongside work from BBC Future, The Guardian, The New Yorker, and The Intercept.READ MORE

First Oral Medication to Treat T1D Approved in Europe


The European Commission (EC) has approved the use of Forxiga (dapagliflozin) as an add-on treatment to insulin therapy for use in in patients with T1D who have a BMI ≥ 27 kg/m2READ MORE

FDA Declines to Approve First Oral Medication for Type 1 Diabetes


The FDA issued a Complete Response Letter for the SGLT-1/2 inhibitor Zynquista (sotagliflozin), declining to approve it for use in T1D at this time. READ MORE

Senseonics Appoints Francine R. Kaufman, M.D. as Chief Medical Officer


Francine R. Kaufman, M.D., a member of Beyond Type 1’s Science Advisory Council, was appointed Chief Medical Officer at Senseonics.READ MORE

Tornado in Alabama; how to help?


Seven minutes, imagine having only seven minutes to seek shelter because a tornado is approaching. That is what residents in Lee County, Alabama experienced yesterday.READ MORE

Half-Price Generic of Humalog Insulin Launched by Lilly


On Monday, March 4, Lilly Diabetes announced in a press release that an authorized generic version of Humalog insulin will be available in United States pharmacies for half the list price of Humalog.READ MORE

Pharma Execs Testify Before Senate on High Drug Prices


Executives from pharmaceutical companies were called on to testify before the Senate Finance Committee to explain the soaring cost of prescription drug prices in the U.S.READ MORE

UCSF Team First to Grow Insulin-Producing Cells from Human Stem Cells


Researchers at UCSF have created insulin-producing cells from human stem cells, an incredible breakthrough and benchmark on the road to curing Type 1 diabetes. This is the first time scientists have been able to achieve this feat of regenerative medicine.READ MORE

Teen with T1D Rationed Insulin to Help Parents


Dillon Hooley started rationing insulin at the beginning of 2018, in an effort to help his parents struggling with finances.READ MORE

Insulin Manufacturers Called on to Explain Skyrocketing Prices


On Tuesday, a group of U.S. Senators led by Patty Murray (D-WA) sent letters to executives at Eli Lilly, Novo Nordisk, and Sanofi demanding information about the rising prices of insulin.  READ MORE

UnitedHealthcare Decision — A Step Backwards for Pump Access


UnitedHealthcare's announcement of a preferred insulin pump for pediatric patients has been denounced by Beyond Type 1 and JDRF.READ MORE

National Health Services to Provide Free CGMs to Pregnant Women with T1D in UK


National Health Services England announced Monday that it would offer continuous glucose monitors to all pregnant women with T1D by 2021. READ MORE

FDA Advisory Vote Split 8-8 on SGLT Inhibitor for T1D


Votes on Zynquista from panel members on the Endocrinologic and Metabolic Drugs Advisory Committee were split 8 to 8. This was the first ever regulatory review for an SGLT inhibitor for use in Type 1 diabetes in the United States.READ MORE

Government Shutdown Leads to Insulin Rationing


Government workers are increasingly unable to afford basic necessities like food, power, and critical medications like insulin.READ MORE

Congressman Introduces “Insulin Access For All Act” for Medicaid and Medicare Beneficiaries


Representative Bobby Rush (D-Ill) introduced the Insulin Access For All Act to eliminate the cost-sharing requirement for patients on Medicare and MedicaidREAD MORE

Join the Fit with Diabetes Challenge


Beyond Type 1 met up with Christel Oerum from Diabetes Strong for a chat about fitness and her next Fit With Diabetes Challenge which is kicking off on January 3.READ MORE

CW Star Unveils Teen Superheroes with Disabilities


Austin Basis details his comic book series "The Kinetix," which features a protagonist who fights crime while maintaining his Type 1 diabetes.READ MORE

All About the Tidepool Loop Program


In Fall of 2018, Tidepool announced plans to deliver an officially supported, FDA-regulated Loop app that will be available via the App Store. They’re calling it the “Tidepool Loop”READ MORE

Research Team Delays Onset of Type 1 Diabetes in Mice


Dr. Massimo Pietropaolo and his team of experimenters at Baylor College of Medicine and the University of Michigan Medical School have determined that certain B cells may have the capacity to delay the onset of T1D.READ MORE

FDA Commissioner Makes Statement on Insulin Pricing


Today, the United States FDA Commissioner Scott Gottlieb, M.D., released a statement detailing a handful of new guidances designed to increase competition and bring down prices across the insulin market. The changes are slated to take effect in 2020.READ MORE

Type 1 Diabetes in Ghana: A Global Community Discussion


James Mansfield details a chat facilitated by Type One Run and Diabetes Youth Care Ghana during which those in attendance were brought up to speed on the various unique challenges faced by Ghanaians with T1D. READ MORE

Dexcom Donates $25,000 to Beyond Type 1


Social media campaign #NoMoreFingerpricks raises funds and awareness for diabetes researchREAD MORE

Introducing Francine Kaufman: Newest Member of Science Advisory Council


Meet Francine Kaufman M.D., the newest member of the Beyond Type 1 Science Advisory Council! Dr. Kaufman recently spoke with Beyond Type 1 about her history of treating diabetes, her work abroad, the global diabetes landscape, and the future of T1D.READ MORE

New Study Reveals the Power of the Diabetes Online Community


You may know the power of the diabetes online community, but does your doctor? Do experts understand what it really means when community members build relationships through social media in the #DOC?READ MORE

ViaCyte Secures $80 Million in Funding to Further Cell-Based Treatment for Diabetes


ViaCyte is leading the charge in stem cell research and regenerative medicine. Their goal? Cell-based long term diabetes treatments - a “functional cure” for Type 1 diabetes. READ MORE

National Health Services To Offer Free Glucose Monitors for T1D in the UK


Beginning April 1, people with Type 1 diabetes in the UK will have the FreeStyle Libre system completely covered, ending issues with access many are currently facing.READ MORE

Meet Alexi on the Beyond Type 1 Leadership Council


Alexi is a writer, artist and actress in the Bay Area. She studied at the New School University in Manhattan as well as the Lee Strasberg Theatre & Film Institute. She has written for multiple publications and websites such as the San Francisco Chronicle and has been a regular contributor for Beyond Type 1 for many years.READ MORE

Giving Thanks For Dr. Lois Jovanovic (1947-2018)


Midwife Jessica Lynn reflects on her time spent under Dr. Lois Jovanovic's tutelage and shares what feels were her biggest contributions to the world of T1D.READ MORE

Crystal Bowersox and Brett Ryan Stewart release new single “The Stuff” to raise awareness for Type 1 diabetes


The two talented musicians operate out of Nashville and have both lived with Type 1 diabetes for most of their lives.READ MORE

Global Diabetes Non-Profit Beyond Type 1 Celebrates World Diabetes Day With Guiness World Record Attempt


Beyond Type 1 is celebrating Sir Frederick Banting’s 127th birthday on Wednesday, November 14th with a coalition of almost 50 organizations attempting to break the Guinness World Record for most contributions to an e-greeting card. READ MORE

Diabeloop Obtains CE Marking for DBLG1


Diabeloop, a French medical technology company that specializes in creating accessible innovations for the Type 1 diabetes community, has obtained CE marking for its DBLG1 System.READ MORE

California Wildfires


Hundreds of thousands evacuate as California wildfires turn deadly.READ MORE

The Deductible Problem


Over the past two decades, deductibles have been steadily rising and a greater percentage of Americans have been enrolling in high deductible health plans.READ MORE

Diabetes Patients Are Being Denied Access to Life-Changing Technology


A recent survey conducted by Dexcom and Beyond Type 1 has revealed that many people with Type 1 diabetes are unaware of continuous glucose monitoring.READ MORE

How much does it cost to produce insulin?


A recent study sets prices for the future of biosimilars.READ MORE

T1D CARE IN THE WAKE OF HURRICANE WILLA


Hurricane Willa has intensified into a Category 5 in the eastern Pacific Ocean and will threaten MexicoREAD MORE

Tandem t:slim X2 Approved in Canada


The Tandem t:slim X2 has received Health Canada license with sales expected to begin in Fall 2018. Read on to learn a bit more about the product and to find out if it’s in the running for your next pump.READ MORE

$2 Million Grant to Power Bionic Pancreas Trials


The iLet Bionic Pancreas System is pocket sized device that will be worn similarly to that of an insulin pump, but only requires the patient to enter body weight, and does not require any carbohydrate counting nor the configuring of any basal or bolus rates or correction ratios.READ MORE

Abbott’s FreeStyle Libre Gains CE Mark In Europe


Earlier this month, Abbott announced that its FreeStyle Libre 2 system had secured CE Mark clearance in the European Union. The system will be launched on a rolling basis throughout Europe, starting in the coming weeks, according to the company.READ MORE

How Paige Powered Up


Off the little Seattle island of San Juan, big things are happening in philanthropy — we're seeing an entire community contribute their resources and talents to help raise awareness and funds for Type 1 diabetes, an autoimmune disease that currently has no cure.READ MORE

Tidepool Announces Plans to Create FDA-Regulated Loop


On Monday, October 8, Tidepool announced plans to deliver an officially supported, FDA-regulated Loop app, available via the App Store. READ MORE

Hurricane Michael


Hurricane Michael has 150 mph winds as it approaches Florida's panhandle. It's almost a Category 5 storm. READ MORE

Research Shows Fridges Might Be Destroying Insulin


A 16-month study has shown that 79% of insulin is kept at temperatures outside of the recommended range. Insulin stored in the fridge is at a much higher risk. READ MORE

5 Takeaways from Diabetics on the Margin


“I think it’s so important that we’re having these kinds of open discussions that people from all different cultures and identities can meet and mix and validate one another. This honestly is the first event that I’ve seen that is specifically speaking to people on the margins.”READ MORE

People Are Dying from Insulin Rationing – Even TV Dramas Are Talking About It


While TV dramas have the propensity to be — well, dramatic — the details of Abby’s story are not only accurate but also more common than one might believe.READ MORE

Beyond Type 1 Receives $300,985 Helmsley Charitable Trust Grant for DKA Awareness Campaign


Beyond Type 1 is excited to announce today that we have received a $300,985 grant from The Leona M. and Harry B Helmsley Charitable Trust to power the next phase of our DKA Awareness Campaign.READ MORE

DiaYogi Dialogues


11 conversations with game changers who teach yoga and live with diabetes.READ MORE

$10 Million Grant to ViaCyte from Gore Supports Cell-Based Treatment for Diabetes


Today, ViaCyte and W.L. Gore & Associates announced a $10 million investment by Gore into ViaCyte. This is the second multimillion dollar investment by Gore, following a first in 2017.READ MORE

The Diabetics on the Margin Event in NYC


If you’ve ever looked at the diabetes space and thought, there isn’t anybody who looks like me here!, the Diabetics on the Margin event, presented by Beyond Type 1 in partnership with Ariel Lawrence, was a major milestone geared toward changing that!READ MORE

CRISPR Therapeutics and ViaCyte’s Strategic Collaboration to Develop Gene‐Edited Stem Cell‐Derived Therapy for Diabetes


Yesterday, CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company that develops transformative gene‐based medicines for serious diseases, and ViaCyte, Inc., a regenerative medicine company, announced their collaboration.READ MORE

T1D Care in the Wake of Typhoon Mangkhut


Typhoon Mangkhut has slammed the Philippines, Hong Kong and continues a destruction path across Southern China.READ MORE

Hurricane Florence


As Hurricane Florence heads toward the U.S. Southeast and Mid-Atlantic, we want to ensure everyone is prepared for the days ahead. If you live in Virginia, North Carolina and South Carolina STAY INFORMED. READ MORE

Tropical Storm Gordon


Tropical Storm Gordon heads towards the northern Gulf Coast threatening AL, FL, and MS.READ MORE

Non-Invasive Glucose Monitoring in the Works at Apple?


On Thursday, August 23rd, Apple filed a patent for what looks like non-invasive glucose monitoring technology. Is the tech giant (finally) developing non-invasive glucose monitoring technology? Here’s what that might look like.READ MORE

Introducing Jesse Was Here – A letter to the Type 1 community


A message from CEO + Co-Founder Sarah Lucas about our newest program Jesse Was Here - supporting those navigating life after a Type 1 death.READ MORE

Hurricane Lane in Hawaii


Hawaii is being threatened by Hurricane Lane the biggest weather threat to Hawaii in decades. We understand this is a stressful and scary situation, that is why want to help. READ MORE

Dexcom Acquires TypeZero Technologies, Including inControl Algorithm


Dexcom announced today that it has acquired TypeZero Technologies, Inc. or "TypeZero". Most notably, this acquisition includes the inControl technology developed to automatically adjust and regulate the delivery of insulin.READ MORE

SGLT Trials Show Lower A1Cs, Higher Chance of DKA


The study conclusions found that Zynquista combined with optimized insulin therapy was associated with sustained A1C reduction, weight loss, lowered insulin doses, fewer episodes of severe hypoglycemia and improved patient-reported outcomes.READ MORE

Ring Around the Courtroom: The Wait for U.S. Biosimilar Insulins


In general, biosimilar medicines are priced lower than the original product from which they are based. Drug price history suggests that at least two generics are needed on the market to lower costs in a meaningful way. If we look at biosimilar insulins, there does appear to be hope for decreased prices, but not as much as some may believe.READ MORE

Ready-To-Use Glucagon Rescue Pen


Xeris Pharmaceuticals announced this week that the company has filed an NDA (new drug application) to the FDA for its Glucagon Rescue Pen.READ MORE

The Insulin Patch and Who Will Bring it to Market


CeQur, a company that develops and sells simple insulin delivery devices primarily for those with Type 2, has recently bought the Calibra insulin delivery patch from Johnson & Johnson. READ MORE

The Future of OpenAPS with Dana Lewis


Beyond Type 1 recently sat down with Dana Lewis, who shared with us how the OpenAPS system has changed her life. Her diabetes journey is fascinating, and Dana gave us a behind-the-scenes look at the technology that can seem almost too good to be true.READ MORE

DugalDiabetes – A Decision Support App for Individualized Mealtime Insulin Dosing


DugalDiabetes is a decision support app focused on mealtime insulin dosing that is customized to you and your experience.READ MORE

Research for Better Management + Cure of Type 1 diabetes


Research to cure and treat Type 1 mostly fits into five areas: 1) beta cell health and regeneration, 2) immunotherapy, 3) replacement beta cells, 4) device/technology innovation and 5) medications for glucose management.READ MORE

Can ATG Delay the Onset of Type 1?


On June 25, 2018, TrialNet announced some promising primary findings from the first year of their two year study on ATG and GCSF. These primary findings suggest that “low dose ATG preserved beta cell function and improved insulin production.”READ MORE

Tortoise vs the Hare – Islet Transplantation vs Technology


The race to find a more effective and non-evasive, injection-free therapy for patients with Type 1 diabetes involves many players. The remaining question is not when, but who is going to win: the tortoise or the hare?READ MORE

Immunotherapy for Type 1 Diabetes


“For a long time, everybody thought that Type 1 would be cured by immunosuppression,” said The Faustman Lab’s Dr. Denise L. Faustman, M.D., Ph.D., but the past 30 years of discovery “have proven that immunostimulation is what’s needed.”READ MORE

Northern California Wildfire Help


We know that during these kinds of emergencies mandatory evacuations are in order and you have very little time to prepare. We want to share information about how to help or receive help if you have been affected by the wildfires.READ MORE

Lilly Files for FDA Approval of Nasal Glucagon


Eli Lilly and Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) and an EU Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for nasal glucagon. If the drug receives approval, it will be the first dry powder nasal spray on market to treat severe hypoglycemia.READ MORE

5 Reasons to Get Screened for Type 1 Diabetes


If you have a relative with Type 1 diabetes, you may be at higher risk of developing the disease, making it imperative that you get screened. The Pathway to Prevention Study is a free and simple blood test that determines your risk of developing Type 1 diabetes before symptoms occur. READ MORE

TEDDY STUDY – Researching the Causes of Type 1 diabetes


Researchers are studying a group of nearly 9,000 children from four countries from birth to 15 years old who are at an elevated risk for Type 1 diabetes.READ MORE

Can an Antihypertensive Drug Preserve Beta Cell Function in Early Type 1 diabetes?


A study published this week in Nature reported that an FDA-approved antihypertensive drug, verapamil, might slow the progression of beta cell destruction at Type 1 diabetes onset.READ MORE

Why Beyond Type 1 Matters: An Interview With Nick Jonas


Jonas explains why Beyond Type 1 is a whole new brand of philanthropy, saying, "I think traditionally the internet has been used as an educational tool for many diseases and things of that nature, but in regards to Type 1 diabetes (T1D), this is the first time social media has really been a defining factor in the outreach and the presence of a non-profit."READ MORE

2018 Abbott Dash to the Finish Line 5K


Join Type One Run for the 2018 Abbott Dash to the Finish Line 5k in New York City on November 3, 2018! At the Abbott Dash to the Finish Line 5K, you’ll be a part of the world-famous TCS New York City Marathon. READ MORE

Supermodel Bambi Talks Type 1 Diabetes


Bambi, 26-year-old Australian model who has been living with Type 1 diabetes for more than half her life caught up with Lauren Bongiorno, a Beyond Type 1 Global Ambassador for a recent Facebook broadcast.READ MORE

T1D Advocate Justin Wright on Living Boldly


Justin Wright, aspiring model, advocate and winner of the Kansas City Dream Factory Award, talks about what T1D advocacy means to him and how he plans on making a difference. READ MORE

Quincy the Koala Gets a Dexcom G6 CGM


Quincy, a koala with Type 1 diabetes who lives in the San Diego Zoo, just got a Dexcom G6 CGM.READ MORE

New Finding Could Improve Depression Treatment in T1D


A new study, recently published in Endocrine Connection, examined the relationship between Type 1 diabetes, depression, and neuroinflammatory responses in the body. The research, titled “Depression in type 1 diabetes was associated with high levels of circulating galectin-3,” was conducted by clinicians at Sweden’s Lund University.READ MORE

Guatemala Disaster Relief


On Sunday, June 3, 2018, the Volcán de Fuego in Guatemala began its eruptive phase. Located approximately 50 kilometers from the Guatemalan capital, the volcano has affected primarily Sacatepéquez, Escuintla and Chimaltenango. READ MORE

Omnipod DASH System from Insulet Receives FDA Clearance


Omnipod DASH(TM) Insulin Management System has received 510(K) clearance from the FDA. This clearance allows Insulet to commercialize this product in the United States, though Insulet has announced that it will begin roll-out through a limited market launch. Full market release is estimated to begin in early 2019 in the United States.READ MORE

Beyond Type 1’s Meet Up in NYC – Join the Community


Beyond Type 1 creates opportunities for the diabetes community to connect in all kinds of ways: through the Beyond Type 1 app, on social media, and in real life. Whether you’ve been living with diabetes for 2.5 months or 25 years, there’s something about being in the company of other people who get it.READ MORE

New iLet Bionic Pancreas System Begins Clinical Trial Testing


Beta Bionics has officially received IDE approval from the FDA to begin a clinical trial, testing the new iLet Bionic Pancreas System.READ MORE

Gut Health Possibly the Key to Type 1 Diabetes Prevention


Recently, a research team from the University of Queensland in Australia began a trial centered around the relationship between the changes in gut microbiota and Type 1 diabetes diagnoses, and whether these findings could help prevent Type 1 diabetes in the future.READ MORE

BEYOND TYPE 1 NAMED AN OFFICIAL CHARITY PARTNER OF THE 2018 TCS NEW YORK CITY MARATHON


NEW YORK, NY, MAY 24, 2018 – For the second year, Beyond Type 1 has been named an Official Charity Partner of the 2018 TCS New York City Marathon, fielding a team of 21 runners from 6 countries. Each of the runners, aged 19 to 66, lives with Type 1 diabetes.READ MORE

Inside the Lilly Diabetes Blogger Summit


This month, a special team within Lilly Diabetes hosted a small group of diabetes bloggers from around the country to participate in a 2-day summit at their new innovation center in Cambridge, Massachusetts.READ MORE

The Low-Carb Diet — The Answer to Managing Type 1 Diabetes?


The American Academy of Pediatrics has released a groundbreaking paper this May about the potential benefits of managing Type 1 Diabetes with a low-carb diet.READ MORE

The Dire Reality of having Type 1 Diabetes in Venezuela


People with Type 1 diabetes in Venezuela are experiencing one of the worst moments in history. They don’t have blood glucose test strips; they can only get insulin at no-cost at hospitals, if they get it at all. And very few can afford insulin from pharmacies when it is in stock.READ MORE

Medtronic’s Guardian Connect CGM + Limited Availability


Medtronic’s Guardian Connect mobile system will begin a “soft” launch during this month through July with a wider release in the fall.READ MORE

DRIFcan and the Edmonton Protocol for Type 1 Diabetes Cure Research


Beyond Type 1 had the pleasure of talking to Melanie Hibbard, the Executive Director of DRIFCan. DRIFCan, or Diabetes Research Institute Foundation Canada, was established in 2005 and their mission is to directly fund cure-based diabetes.READ MORE